Literature DB >> 1786595

Ornithine decarboxylase activity during development of the mouse inner ear in vivo and in vitro.

S A Crann1, T R Van de Water, J Schacht.   

Abstract

Ornithine decarboxylase activity was determined during the development of the peripheral auditory system in the murine otocyst with the goal of understanding the role of this enzyme in the morphological and functional maturation of the inner ear. At gestational days 11 and 12 enzyme activity was more than 10-fold higher than adult levels. A sharp decline occurred between day 12 and 13 after which activity rose to a peak around day 15. Activity then dropped continuously until near-adult levels were reached at birth. A lower specific activity of ODC but a similar time-course was seen in otocysts explanted at gestational day 13 and subsequently cultured for 6 days. For two stages of development, enzyme activity and binding of 3H-alpha-difluoromethylornithine were compared. The four-fold difference in enzymatic activity on gestational days 15 and 17 was paralleled by a similar difference in binding. Ornithine decarboxylase activity during inner ear development therefore seems primarily regulated at the level of protein synthesis. Ornithine decarboxylase activity correlates with major inductive events in the morphogenesis of the cartilagenous otic capsule that serves as a template for the formation of the bony labyrinth. The pattern of activity may reflect the changes in the head mesenchyme that is recruited by the otocyst to aggregate and form its protective otic capsule.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1786595     DOI: 10.1007/bf00340878

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  24 in total

1.  The appearance of an ornithine decarboxylase inhibitory protein upon the addition of putrescine to cell cultures.

Authors:  W F Fong; J S Heller; E S Canellakis
Journal:  Biochim Biophys Acta       Date:  1976-04-23

2.  Formation of junctional complexes in otocysts developed in vitro. A freeze-fracture study.

Authors:  D Berggren; D Bagger-Sjöbäck; M Anniko
Journal:  Acta Otolaryngol       Date:  1987 Jul-Aug       Impact factor: 1.494

3.  Changes in the types of collagen synthesized during chondrogenesis of the mouse otic capsule.

Authors:  A D'Amico-Martel; T R Van de Water; J A Wootton; R R Minor
Journal:  Dev Biol       Date:  1987-04       Impact factor: 3.582

4.  An animal model of hearing loss from alpha-difluoromethylornithine.

Authors:  C Jansen; D E Mattox; K D Miller; W E Brownell
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1989-10

5.  Stabilization of erythrocyte membranes by polyamines.

Authors:  S K Ballas; N Mohandas; L J Marton; S B Shohet
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

6.  Reciprocal regulation of ornithine decarboxylase and choline kinase activities by their respective reaction products in the developing rat cerebellar cortex.

Authors:  G M Gilad; V H Gilad
Journal:  J Neurochem       Date:  1984-12       Impact factor: 5.372

7.  Androgen-regulated ornithine decarboxylase mRNAs of mouse kidney.

Authors:  F G Berger; P Szymanski; E Read; G Watson
Journal:  J Biol Chem       Date:  1984-06-25       Impact factor: 5.157

8.  Dysmorphogenesis of the inner ear: disruption of extracellular matrix (ECM) formation by an L-proline analog in otic explants.

Authors:  T R Van de Water; V Galinovic-Schwartz
Journal:  J Craniofac Genet Dev Biol       Date:  1986

9.  Inhibition of inner ear ornithine decarboxylase by neomycin in-vitro.

Authors:  C M Henley; H J Gerhardt; J Schacht
Journal:  Brain Res Bull       Date:  1987-12       Impact factor: 4.077

10.  Control of nucleic acid and protein synthesis in developing brain, kidney, and heart of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase.

Authors:  T A Slotkin; D Persons; R J Slepetis; D Taylor; J Bartolome
Journal:  Teratology       Date:  1984-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.